Literature DB >> 28446798

Novel missense mutation in DLL4 in a Japanese sporadic case of Adams-Oliver syndrome.

Miwako Nagasaka1, Mariko Taniguchi-Ikeda1,2, Hidehito Inagaki3, Yuya Ouchi3, Daisuke Kurokawa1, Keiji Yamana1, Risa Harada4, Kandai Nozu1, Yoshitada Sakai4, Sushil K Mishra5, Yoshiki Yamaguchi5, Ichiro Morioka1, Tatsushi Toda6, Hiroki Kurahashi3, Kazumoto Iijima1.   

Abstract

Adams-Oliver syndrome (AOS, OMIM; 100300) is a rare genetic disease characterized by aplasia cutis congenita, terminal transverse limb defects and cutis marmorata with vascular anomalies such as congenital heart defects. The etiology of this syndrome has remained largely unknown but defective Notch signaling during vascular formation has been suggested. Here we describe a sporadic Japanese newborn case with clinically diagnosed AOS. Trio whole-exome sequencing identified a de novo, novel, heterozygous missense mutation in the Delta-like 4 ligand gene (DLL4 c.572G>A, p.Arg191His) in the patient. DLL4 functions as a requisite ligand for NOTCH1 receptor, which is essential for vascular formation. Amino acid substitution of Arg191 to His was predicted by molecular models to interfere with direct binding between DLL4 and NOTCH1. DLL4 has recently been identified as a causative gene of an autosomal dominant type of AOS with milder symptoms. The case described here showed gradual recovery from skull defects after birth and no psychomotor developmental delay has been observed. This is the second report of an AOS case with DLL4 mutation, and the phenotypic characteristics between the two cases are compared and discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28446798     DOI: 10.1038/jhg.2017.48

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

1.  Dll4, a novel Notch ligand expressed in arterial endothelium.

Authors:  J R Shutter; S Scully; W Fan; W G Richards; J Kitajewski; G A Deblandre; C R Kintner; K L Stark
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  Multifocal aplasia cutis congenita, distal limb hemimelia, and cutis marmorata telangiectatica in a patient with Adams-Oliver syndrome.

Authors:  K Bork; J Pfeifle
Journal:  Br J Dermatol       Date:  1992-08       Impact factor: 9.302

3.  Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies.

Authors:  Laura Southgate; Rajiv D Machado; Katie M Snape; Martin Primeau; Dimitra Dafou; Deborah M Ruddy; Peter A Branney; Malcolm Fisher; Grace J Lee; Michael A Simpson; Yi He; Teisha Y Bradshaw; Bettina Blaumeiser; William S Winship; Willie Reardon; Eamonn R Maher; David R FitzPatrick; Wim Wuyts; Martin Zenker; Nathalie Lamarche-Vane; Richard C Trembath
Journal:  Am J Hum Genet       Date:  2011-05-13       Impact factor: 11.025

4.  Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.

Authors:  Josephina A N Meester; Laura Southgate; Anna-Barbara Stittrich; Hanka Venselaar; Sander J A Beekmans; Nicolette den Hollander; Emilia K Bijlsma; Appolonia Helderman-van den Enden; Joke B G M Verheij; Gustavo Glusman; Jared C Roach; Anna Lehman; Millan S Patel; Bert B A de Vries; Claudia Ruivenkamp; Peter Itin; Katrina Prescott; Sheila Clarke; Richard Trembath; Martin Zenker; Maja Sukalo; Lut Van Laer; Bart Loeys; Wim Wuyts
Journal:  Am J Hum Genet       Date:  2015-08-20       Impact factor: 11.025

5.  Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.

Authors:  John Ridgway; Gu Zhang; Yan Wu; Scott Stawicki; Wei-Ching Liang; Yvan Chanthery; Joe Kowalski; Ryan J Watts; Christopher Callahan; Ian Kasman; Mallika Singh; May Chien; Christine Tan; Jo-Anne S Hongo; Fred de Sauvage; Greg Plowman; Minhong Yan
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

6.  Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome.

Authors:  Ranad Shaheen; Eissa Faqeih; Asma Sunker; Heba Morsy; Tarfa Al-Sheddi; Hanan E Shamseldin; Nouran Adly; Mais Hashem; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2011-08-04       Impact factor: 11.025

7.  Vascular pathogenesis of transverse limb reduction defects.

Authors:  H E Hoyme; K L Jones; M I Van Allen; B S Saunders; K Benirschke
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

8.  Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome.

Authors:  Ranad Shaheen; Mona Aglan; Kim Keppler-Noreuil; Eissa Faqeih; Shinu Ansari; Kim Horton; Adel Ashour; Maha S Zaki; Fatema Al-Zahrani; Anna M Cueto-González; Ghada Abdel-Salam; Samia Temtamy; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2013-03-21       Impact factor: 11.025

Review 9.  Adams-Oliver syndrome revisited.

Authors:  C B Whitley; R J Gorlin
Journal:  Am J Med Genet       Date:  1991-09-01

10.  Structural biology. Structural basis for Notch1 engagement of Delta-like 4.

Authors:  Vincent C Luca; Kevin M Jude; Nathan W Pierce; Maxence V Nachury; Suzanne Fischer; K Christopher Garcia
Journal:  Science       Date:  2015-02-20       Impact factor: 47.728

View more
  5 in total

1.  Functional genomics and gene-environment interaction highlight the complexity of congenital heart disease caused by Notch pathway variants.

Authors:  Gavin Chapman; Julie L M Moreau; Eddie I P; Justin O Szot; Kavitha R Iyer; Hongjun Shi; Michelle X Yam; Victoria C O'Reilly; Annabelle Enriquez; Joelene A Greasby; Dimuthu Alankarage; Ella M M A Martin; Bernadette C Hanna; Matthew Edwards; Steven Monger; Gillian M Blue; David S Winlaw; Helen E Ritchie; Stuart M Grieve; Eleni Giannoulatou; Duncan B Sparrow; Sally L Dunwoodie
Journal:  Hum Mol Genet       Date:  2020-03-13       Impact factor: 6.150

2.  Murine Model of Cardiac Defects Observed in Adams-Oliver Syndrome Driven by Delta-Like Ligand-4 Haploinsufficiency.

Authors:  Prashan De Zoysa; Omar Toubat; Drayton Harvey; Jongkyu Choi; S Ram Kumar
Journal:  Stem Cells Dev       Date:  2021-05-31       Impact factor: 4.390

3.  Elucidating the genetic architecture of Adams-Oliver syndrome in a large European cohort.

Authors:  Josephina A N Meester; Maja Sukalo; Kim C Schröder; Denny Schanze; Gareth Baynam; Guntram Borck; Nuria C Bramswig; Duygu Duman; Brigitte Gilbert-Dussardier; Muriel Holder-Espinasse; Peter Itin; Diana S Johnson; Shelagh Joss; Hannele Koillinen; Fiona McKenzie; Jenny Morton; Heike Nelle; Willie Reardon; Claudia Roll; Mustafa A Salih; Ravi Savarirayan; Ingrid Scurr; Miranda Splitt; Elizabeth Thompson; Hannah Titheradge; Colm P Travers; Lionel Van Maldergem; Margo Whiteford; Dagmar Wieczorek; Geert Vandeweyer; Richard Trembath; Lut Van Laer; Bart L Loeys; Martin Zenker; Laura Southgate; Wim Wuyts
Journal:  Hum Mutat       Date:  2018-07-04       Impact factor: 4.878

4.  A novel DLL4 missense mutation in a Chinese patient with Adams-Oliver syndrome.

Authors:  Xue Yu; Rong-Rong Wang; Shi-Rui Han; Xiao Bai; Xiaerbati Habulieti; Yang Sun; Li-Wei Sun; Han Zhang; Amjad Khan; Xue Zhang
Journal:  Chin Med J (Engl)       Date:  2019-07-20       Impact factor: 2.628

5.  Delta-like ligand-4 regulates Notch-mediated maturation of second heart field progenitor-derived pharyngeal arterial endothelial cells.

Authors:  Prashan De Zoysa; Omar Toubat; Drayton C Harvey; Christopher Yi; Jiang Liu; Susana Cavallero; Young-Kwon Hong; Henry M Sucov; Subramanyan Ram Kumar
Journal:  J Cell Mol Med       Date:  2022-09-09       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.